List of bibliographic references
Number of relevant bibliographic references: 7.
List of associated KwdEn.i
Nombre de documents | Descripteur |
3 | Humans |
1 | Adult |
1 | Aged |
1 | Aged, 80 and over |
1 | Antibodies, Monoclonal, Murine-Derived (administration & dosage) |
1 | Antimetabolites, Antineoplastic (therapeutic use) |
1 | Antineoplastic Agents (therapeutic use) |
1 | Antineoplastic Combined Chemotherapy Protocols (administration & dosage) |
1 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
1 | Antineoplastic agent |
1 | Azacitidine (therapeutic use) |
1 | Blast Crisis (drug therapy) |
1 | Blast Crisis (pathology) |
1 | Chlorambucil |
1 | Clinical management |
1 | Combined Modality Therapy |
1 | Consensus |
1 | Cooperation |
1 | Cure |
1 | Cyclophosphamide (administration & dosage) |
1 | Disease Management |
1 | Disease-Free Survival |
1 | Drug Administration Schedule |
1 | Drug combination |
1 | Europe |
1 | Female |
1 | Focal Adhesion Kinase 1 (genetics) |
1 | Follow-Up Studies |
1 | Gene Expression |
1 | Genetic Testing |
1 | Hematology |
1 | Hematopoietic Stem Cell Transplantation |
1 | Human |
1 | Immunophenotyping |
1 | Immunotherapy |
1 | International Agencies |
1 | International Cooperation |
1 | Leukemia |
1 | Leukemia, Lymphocytic, Chronic, B-Cell (enzymology) |
1 | Leukemia, Lymphocytic, Chronic, B-Cell (genetics) |
1 | Leukemia, Lymphocytic, Chronic, B-Cell (therapy) |
1 | Leukemia, Myeloid, Acute (classification) |
1 | Leukemia, Myeloid, Acute (diagnosis) |
1 | Leukemia, Myeloid, Acute (drug therapy) |
1 | Leukemia, Myeloid, Acute (genetics) |
1 | Leukemia, Myeloid, Acute (mortality) |
1 | Leukemia, Myeloid, Acute (pathology) |
1 | Leukemia, Myeloid, Acute (therapy) |
1 | Male |
1 | Medicine |
1 | Neoplasm Staging |
1 | Neoplasm, Residual |
1 | Practice Guidelines as Topic |
1 | Prognosis |
1 | Proportional Hazards Models |
1 | Prospective Studies |
1 | RNA, Messenger (genetics) |
1 | RNA, Messenger (metabolism) |
1 | RNA, Neoplasm (genetics) |
1 | RNA, Neoplasm (metabolism) |
1 | Recommendation |
1 | Recurrence |
1 | Research |
1 | Retrospective Studies |
1 | Risk Factors |
1 | Rituximab |
1 | Survival Rate |
1 | Transplantation, Autologous |
1 | Treatment Outcome |
1 | Vidarabine (administration & dosage) |
1 | Vidarabine (analogs & derivatives) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Hartmut Döhner"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "Hartmut Döhner" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Hartmut Döhner
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 | |